| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Specialty | $366.31M | $366.31M | $366.31M | $366.31M | $366.31M | $366.31M | $366.31M | $366.31M |
| Affordable Medicines | $162.76M | $162.55M | $161.66M | $161.72M | $161.63M | $160.17M | $159.69M | $158.02M |
| AvKARE | $69.47M | $69.47M | $69.47M | $69.47M | $69.47M | $69.47M | $69.47M | $69.47M |
| Total | $598.53M | $598.32M | $597.44M | $597.5M | $597.41M | $595.95M | $595.47M | $593.8M |